News
8h
Pharmaceutical Technology on MSNADHD drugs back in the spotlight after study debunks rising prevalenceA study found no rise in ADHD cases, though some drugs for the disorder are still in shortage amid high demand.
10h
Week99er on MSNNexus International’s $1.45bn Target to Test Founder Gurhan Kiziloz’s Unique StyleGurhan Kiziloz does not view his attention-deficit hyperactivity disorder (ADHD) as a liability. “It’s a superpower,” he said ...
2d
News-Medical.Net on MSNADHD linked to higher risk of irritable bowel syndrome, global study revealsA global meta-analysis found that people with ADHD are significantly more likely to have irritable bowel syndrome (IBS), ...
What can a parent do about their child who can’t focus and has been labeled with ADHD (Attention-Deficit/Hyperactivity ...
Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are among the most well-known ...
A novel triple reuptake inhibitor is efficacious and ‘clinically meaningful’ for adult attention-deficit/hyperactivity ...
Attention-deficit/hyperactivity disorder disrupts executive function, making follow-through hard. With structure and support, ...
Many adults, like Moss, have struggled with issues they couldn't explain throughout their entire lives — until their children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results